
The Experimental Therapeutics Program at The Georgia Cancer Center (Âé¶¹AV) drives innovation in cancer research and precision oncology by uniting scientists and clinicians to develop the next generation of cellular (CAR T) and targeted therapies.
Our Goal & Focus Translational Impact Membership Faculty
Research
Health Sciences Campus
Our goal is to translate cutting-edge discoveries in genomics, proteomics, and immunotherapy into more effective and personalized treatments for cancer patients.
Our Focus is to advance translational cancer research through:
Our investigators partner with the NCI NExT Program and the Experimental Therapeutics Clinical Trials Network (ETCTN) to move promising discoveries efficiently from the laboratory to early-phase clinical trials, accelerating the delivery of innovative cancer treatments to patients.
Research Themes
The program includes scientists and clinicians from departments of Pathology, Surgery, Medicine, Radiation Oncology, Pediatrics Oncology, Biochemistry and Molecular Biology, Chemistry, Pharmacology, Physiology, Neuroscience, and Cell Biology, as well as the Immunology Center of Georgia and the Cardiovascular Center.
Disease Areas
Our investigators focus on a broad range of cancers, including:
Breast cancer • Liver cancer • Melanoma and other skin malignancies • Head and neck cancers • Hematologic malignancies • Neuro-oncology • Urologic oncology • Pediatric cancers







Susan Gearhart, MD







Rachael Piver, MD
762-375-2669



Akash Shah


Marian Symmes Johnson, MD, FACOG

Rachel Watson





Jorge Nochebuena, PhD

The Georgia Cancer Center at Âé¶¹AV is dedicated to reducing the burden of cancer in Georgia and across the globe through superior care, innovation, and education. Through unprecedented expansion, the Georgia Cancer Center is providing access to more first-in-the-nation clinical trials, world-renowned experts and life-saving options.
Follow the Georgia Cancer Center